• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性和神经纤维瘤病 II 型相关前庭神经鞘瘤的微环境:同一肿瘤还是不同肿瘤?一项比较影像学和神经病理学研究。

The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study.

机构信息

1Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre.

2Division of Informatics, Imaging and Data Sciences, Wolfson Molecular Imaging Centre (WMIC), University of Manchester.

出版信息

J Neurosurg. 2020 May 29;134(5):1419-1429. doi: 10.3171/2020.3.JNS193230. Print 2021 May 1.

DOI:10.3171/2020.3.JNS193230
PMID:32470937
Abstract

OBJECTIVE

Inflammation and angiogenesis may play a role in the growth of sporadic and neurofibromatosis type 2 (NF2)-related vestibular schwannoma (VS). The similarities in microvascular and inflammatory microenvironment have not been investigated. The authors sought to compare the tumor microenvironment (TME) in sporadic and NF2-related VSs using a combined imaging and tissue analysis approach.

METHODS

Diffusion MRI and high-temporal-resolution dynamic contrast-enhanced (DCE) MRI data sets were prospectively acquired in 20 NF2-related and 24 size-matched sporadic VSs. Diffusion metrics (mean diffusivity, fractional anisotropy) and DCE-MRI-derived microvascular biomarkers (transfer constant [Ktrans], fractional plasma volume, tissue extravascular-extracellular space [ve], longitudinal relaxation rate, tumoral blood flow) were compared across both VS groups, and regression analysis was used to evaluate the effect of tumor size, pretreatment tumor growth rate, and tumor NF2 status (sporadic vs NF2-related) on each imaging parameter. Tissues from 17 imaged sporadic VSs and a separate cohort of 12 NF2-related VSs were examined with immunohistochemistry markers for vessels (CD31), vessel permeability (fibrinogen), and macrophage density (Iba1). The expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 was evaluated using immunohistochemistry, Western blotting, and double immunofluorescence.

RESULTS

Imaging data demonstrated that DCE-MRI-derived microvascular characteristics were similar in sporadic and NF2-related VSs. Ktrans (p < 0.001), ve (p ≤ 0.004), and tumoral free water content (p ≤ 0.003) increased with increasing tumor size and pretreatment tumor growth rate. Regression analysis demonstrated that with the exception of mean diffusivity (p < 0.001), NF2 status had no statistically significant effect on any of the imaging parameters or the observed relationship between the imaging parameters and tumor size (p > 0.05). Tissue analysis confirmed the imaging metrics among resected sporadic VSs and demonstrated that across all VSs studied, there was a close association between vascularity and Iba1+ macrophage density (r = 0.55, p = 0.002). VEGF was expressed by Iba1+ macrophages.

CONCLUSIONS

The authors present the first in vivo comparative study of microvascular and inflammatory characteristics in sporadic and NF2-related VSs. The imaging and tissue analysis results indicate that inflammation is a key contributor to TME and should be viewed as a therapeutic target in both VS groups.

摘要

目的

炎症和血管生成可能在散发和神经纤维瘤病 2 型(NF2)相关前庭神经鞘瘤(VS)的生长中发挥作用。微血管和炎症微环境之间的相似性尚未得到研究。作者试图使用联合成像和组织分析方法比较散发和 NF2 相关 VS 的肿瘤微环境(TME)。

方法

前瞻性地在 20 例 NF2 相关和 24 例大小匹配的散发 VS 中采集扩散 MRI 和高时间分辨率动态对比增强(DCE)MRI 数据集。比较两组 VS 的扩散指标(平均弥散度、各向异性分数)和 DCE-MRI 衍生的微血管生物标志物(转运常数[Ktrans]、血浆分数、组织血管外细胞外空间[ve]、纵向弛豫率、肿瘤血流),并进行回归分析以评估肿瘤大小、预处理肿瘤生长率和肿瘤 NF2 状态(散发与 NF2 相关)对每个成像参数的影响。对 17 例成像的散发 VS 组织和单独的 12 例 NF2 相关 VS 组织进行免疫组织化学标记血管(CD31)、血管通透性(纤维蛋白原)和巨噬细胞密度(Iba1)检测。使用免疫组织化学、Western 印迹和双重免疫荧光评估血管内皮生长因子(VEGF)和 VEGF 受体 1 的表达。

结果

影像学数据表明,散发和 NF2 相关 VS 的 DCE-MRI 衍生微血管特征相似。Ktrans(p<0.001)、ve(p≤0.004)和肿瘤游离水含量(p≤0.003)随肿瘤大小和预处理肿瘤生长率的增加而增加。回归分析表明,除平均弥散度(p<0.001)外,NF2 状态对任何成像参数或观察到的成像参数与肿瘤大小之间的关系均无统计学意义(p>0.05)。组织分析证实了切除的散发 VS 中的影像学指标,并表明在所研究的所有 VS 中,血管生成与 Iba1+巨噬细胞密度之间存在密切关联(r=0.55,p=0.002)。Iba1+巨噬细胞表达 VEGF。

结论

作者首次进行了散发和 NF2 相关 VS 微血管和炎症特征的体内比较研究。影像学和组织分析结果表明,炎症是 TME 的关键贡献者,应被视为两组 VS 的治疗靶点。

相似文献

1
The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study.散发性和神经纤维瘤病 II 型相关前庭神经鞘瘤的微环境:同一肿瘤还是不同肿瘤?一项比较影像学和神经病理学研究。
J Neurosurg. 2020 May 29;134(5):1419-1429. doi: 10.3171/2020.3.JNS193230. Print 2021 May 1.
2
Neurofibromatosis type 2 versus sporadic vestibular schwannoma: The utility of MR diffusion and dynamic contrast-enhanced imaging.神经纤维瘤病 2 型与散发性前庭神经鞘瘤:MR 扩散和动态对比增强成像的应用。
J Neuroimaging. 2022 May;32(3):554-560. doi: 10.1111/jon.12966. Epub 2022 Jan 17.
3
Endoglin (CD105) expression in neurofibromatosis type 2 vestibular schwannoma.神经纤维瘤病 2 型前庭神经鞘瘤中的内胚层蛋白(CD105)表达。
Head Neck. 2019 Oct;41(10):3612-3617. doi: 10.1002/hed.25881. Epub 2019 Jul 16.
4
Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.炎症和血管通透性与散发性前庭神经鞘瘤的生长相关。
Neuro Oncol. 2019 Feb 19;21(3):314-325. doi: 10.1093/neuonc/noy177.
5
Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.伽玛刀放射外科治疗神经纤维瘤病 2 型伴生长性前庭神经鞘瘤患者:与散发性前庭神经鞘瘤的匹配队列研究。
J Neurosurg. 2018 Jan;128(1):49-59. doi: 10.3171/2016.9.JNS161463. Epub 2017 Jan 27.
6
Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis.源自动态对比增强磁共振成像的血管生物标志物可预测2型神经纤维瘤病中前庭神经鞘瘤对抗血管生成治疗的反应。
Neuro Oncol. 2016 Feb;18(2):275-82. doi: 10.1093/neuonc/nov168. Epub 2015 Aug 26.
7
Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.2型神经纤维瘤病患者前庭神经鞘瘤生长的预测因素。
J Neurosurg. 2002 Feb;96(2):217-22. doi: 10.3171/jns.2002.96.2.0217.
8
Facial Nerve Outcomes After Vestibular Schwannoma Microsurgical Resection in Neurofibromatosis Type 2.神经纤维瘤病 2 型前庭神经鞘瘤显微切除后面神经功能结果。
Otolaryngol Head Neck Surg. 2021 Apr;164(4):850-858. doi: 10.1177/0194599820954144. Epub 2020 Sep 22.
9
Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.2型神经纤维瘤病患者的前庭神经鞘瘤生长:一项纵向研究。
J Neurosurg. 2002 Feb;96(2):223-8. doi: 10.3171/jns.2002.96.2.0223.
10
Long-term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration.神经纤维瘤病2型中前庭神经鞘瘤的长期生长速率:体积考量
Laryngoscope. 2016 Oct;126(10):2358-62. doi: 10.1002/lary.25976. Epub 2016 Apr 14.

引用本文的文献

1
Skull-meninges-brain connectivity and extra-axial brain tumours.颅骨-脑膜-脑连接与脑外肿瘤
Brain Commun. 2025 Aug 21;7(5):fcaf311. doi: 10.1093/braincomms/fcaf311. eCollection 2025.
2
Investigating cochlear cellular dynamics in neurofibromatosis type 2-associated schwannomatosis: a histopathological study.2型神经纤维瘤病相关神经鞘瘤病中耳蜗细胞动力学的研究:一项组织病理学研究
Front Neurol. 2025 Aug 15;16:1650470. doi: 10.3389/fneur.2025.1650470. eCollection 2025.
3
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab.
全身MRI评估全身使用贝伐单抗的NF2相关神经鞘瘤病患者的周围病变。
J Neurooncol. 2025 Jun 10. doi: 10.1007/s11060-025-05100-2.
4
Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities.多平台分子分析揭示了与神经纤维瘤病2型相关的前庭神经鞘瘤的两个分子亚组,它们具有不同的肿瘤微环境和治疗易感性。
Acta Neuropathol. 2025 May 9;149(1):47. doi: 10.1007/s00401-025-02883-6.
5
Emerging strategies for the prediction of behaviour, growth, and treatment response in vestibular schwannoma.预测前庭神经鞘瘤行为、生长及治疗反应的新兴策略。
Acta Neurochir (Wien). 2025 Apr 22;167(1):116. doi: 10.1007/s00701-025-06522-7.
6
Why Consider Aspirin for the Treatment of Vestibular Schwannoma? A Brief Review and Randomized, Double-Blind, Placebo-Controlled Study Proposal.为何考虑用阿司匹林治疗前庭神经鞘瘤?简要综述及随机双盲安慰剂对照研究方案。
Laryngoscope Investig Otolaryngol. 2025 Apr 1;10(2):e70121. doi: 10.1002/lio2.70121. eCollection 2025 Apr.
7
Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma.NF2相关的神经鞘瘤病性前庭神经鞘瘤中免疫细胞环境的空间图谱。
Nat Commun. 2025 Mar 26;16(1):2944. doi: 10.1038/s41467-025-57586-z.
8
Current molecular understanding of central nervous system schwannomas.中枢神经系统神经鞘瘤的当前分子学认识。
Acta Neuropathol Commun. 2025 Feb 5;13(1):24. doi: 10.1186/s40478-025-01937-w.
9
Understanding Permeability Changes in Vestibular Schwannomas as Part of the Dynamic Response to Radiosurgery Using Golden-Angle Radial Sparse Parallel Imaging: A Retrospective Study.利用黄金角径向稀疏并行成像理解前庭神经鞘瘤的渗透性变化作为对放射外科动态反应的一部分:一项回顾性研究。
Neurosurgery. 2024 Dec 3;97(1):157-165. doi: 10.1227/neu.0000000000003288.
10
Dynamic contrast-enhanced and diffusion-weighted MR imaging for predicting tumor growth of sporadic vestibular schwannomas: A prospective study.动态对比增强磁共振成像和扩散加权磁共振成像预测散发性前庭神经鞘瘤的肿瘤生长:一项前瞻性研究。
Neuro Oncol. 2025 May 15;27(4):1116-1127. doi: 10.1093/neuonc/noae252.